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Abstract
Background: Shared decision-making (SDM) is a process whereby clinicians and patients work together to select
treatments based on both the patient’s preferences and clinical evidence. Although patients with psychotic
disorders want to participate more in decisions regarding their care, they have limited opportunities to do so
because of various barriers. Knowing about health professionals’ experiences with SDM is important toward
achieving successful implementation. The study aim was to describe and explore health professionals’ SDM
experiences with patients with psychotic disorders.
Methods: Three focus group interviews were conducted, with a total of 18 health professionals who work at one
of three Norwegian community mental health centres where patients with psychotic disorders are treated. We
applied a descriptive and exploratory approach using qualitative content analysis.
Results: Health professionals primarily understand the SDM concept to mean giving patients information and
presenting them with a choice between different antipsychotic medications. Among the barriers to SDM, they
emphasized that patients with psychosis have a limited understanding of their health situation and that time is
needed to build trust and alliances. Health professionals mainly understand patients with psychotic disorders as a
group with limited abilities to make their own decisions. They also described the concept of SDM with little
consideration of presenting different treatment options. Psychological or social interventions were often presented
as complementary to antipsychotic medications, rather than as an alternative to them.
Conclusion: Health professionals’ understanding of SDM is inconsistent with the definition commonly used in the
literature. They consider patients with psychotic disorders to have limited abilities to participate in decisions
regarding their own treatment. These findings suggest that health professionals need more theoretical and practical
training in SDM.
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Background
Shared decision-making (SDM) is often defined as “a
process in which clinicians and patients work together to
select tests, treatments, management or support packages,
based on clinical evidence and the patient’s informed pref-
erences” [1]. SDM involves presenting information about
the patient’s health issue and treatment options, acknow-
ledging their values and preferences, discussing pros and
cons, and considering the patients’ abilities and self-efficacy.
Further, when the health professional presents their recom-
mendation, the SDM practice is to check and clarify the pa-
tient’s understanding, make or explicitly defer a decision,
and arrange follow-up [2]. On a continuum from clinician-
led to patient-led decision-making, SDM practice is consid-
ered an intermediate model of collaboration [3, 4].
User involvement and voluntariness have been two of
the most important political guidelines for mental health
work over recent decades [5, 6]. SDM is closely connected
to user involvement, as it aims to strengthen the patient’s
decisional position [7]. In recent decades, SDM has gar-
nered growing interest, and it continues to be promoted
in an effort to improve the quality of services [1]. How-
ever, implementation in routine mental health care has
been limited [3] and even less accessible to those with se-
vere mental illness [4], despite their wanting to participate
more in decisions regarding their care [8–10].
A cross-sectional survey of 846 outpatients found that
having schizophrenia is a risk factor for being involved
with lower levels of SDM practice [11]. A review found
that SDM in mental health care occurs less often than
patients desire, and that health professionals may ap-
proach patients with schizophrenia with a directive style
or even the use of pressure [12]. The same review
showed that health care providers see patients’ reduced
decisional capacity as a major barrier to implementing
SDM in mental health care [12].
A structured questionnaire of 352 psychiatrists ex-
plored their use of SDM in schizophrenia treatment, re-
vealing that SDM was seen as useful for patients who
exhibited insight, were well-informed, or explicitly
demanded participation [13]. However, SDM was not
judged to be an appropriate approach in cases of poten-
tially reduced decisional capacity, and the psychiatrists
expressed doubts about whether they could accept these
patients as competent partners in medical decisions
about issues such as hospitalization or antipsychotic
medication [13]. Other qualitative studies of consultant
psychiatrists’ experiences with prescribing antipsychotic
medications also support the notion that patients’ deci-
sional capacity can be a barrier to SDM [14, 15].
A 2017 amendment to the Norwegian mental health
act states that patients may refuse treatment if they are
considered competent to consent [16]. Being competent
means they understand the information relevant to their
specific health situation, recognize the factors in their
unique situation, can see the consequences of various
treatment options for them personally, can reason about
relevant information in weighing various treatment op-
tions, and have the ability to communicate their choice
[17]. The amendment indicates that patients who regain
their decisional capacity may, at any time, terminate a
treatment which has been initiated. However, this does
not apply if there is an immediate and serious danger to
the patient’s life or to the life or health of others [16].
Involving service users is a decisive component of con-
temporary health care [6, 18] and a broad national
movement to implement SDM is underway in Norway
[19]. The national health portal recently published a de-
cision aid for patients with a psychotic disorder [20].
The hospital trusts are required to ensure that mental
health care patients are, as far as it is reasonable, able to
choose between different treatment options, including
mental health treatment without medication [21].
Further research on health professionals’ experiences
with practicing SDM with patients with psychotic disor-
ders is needed, so that we may better understand how to
implement this practice. The study aim was to describe
and explore health professionals’ understanding of, and
experiences with, SDM, and the barriers to using SDM
with patients with psychotic disorders.
Methods
Design
This qualitative focus group study of health professionals
used a descriptive and exploratory design [22], with an
inductive approach [23] following Graneheim and Lund-
man’s qualitative content analysis [24]. The analysis fo-
cused on subject and context, emphasizing differences
between and similarities within codes and categories
[23]. The study’s epistemological point of view was
within a phenomenological and hermeneutic tradition.
Implementation support and training
This study is an independent part of a larger project in-
vestigating the implementation of four different
evidence-based practices (EBP) for psychosis treatment:
antipsychotic medication, family interventions, somatic
health care, and illness management and recovery [25].
For the larger project, all participating community
mental health centres (CMHC) and hospital depart-
ments selected two EBP to implement. They were ran-
domized to receive implementation support for one EBP
and no support for the other. The degree to which each
of the EBP were implemented was assessed four times
over 18 months using a five-point fidelity scale (1 = poor
fidelity, 5 = high fidelity). Each CMHC was offered in-
person implementation support biweekly for 6 months
and then monthly for an additional 12 months. The aim
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of the support was to help health professionals identify
and overcome barriers, and to engage them in imple-
menting the assigned EBP [25].
One of the 15 subscales in the fidelity measurement
tool for antipsychotic medication is the use of SDM [26].
Thus, the study’s implementation support included SDM
practice and 14 other components. Eight sites were ran-
domized to receive implementation support for the anti-
psychotic medication EBP. These sites were offered a
one-day workshop with Norwegian experts on anti-
psychotic medication management. An average of nine
leaders and clinicians from each site participated. SDM
was one of the workshop topics. The mean fidelity score
on the SDM subscale for the eight sites was 1.63 (stand-
ard deviation 0.92) after 18 months. Five sites scored 1,
one site scored 2, and two sites scored 3.
Recruitment and setting
Health professionals were recruited from CMHCs which
were offered implementation support for the anti-
psychotic medication EBP. To achieve a sample with
representative variation in experiences with SDM, we
identified and contacted four CMHCs with a range in
the degree of their fidelity ratings for SDM implementa-
tion. We provided brief information about the study,
followed by an invitation to present the study. Two
CMHCs accepted at that stage, after which a fifth
CMHC was invited, and agreed, to participate. A total of
18 health professionals from the three CMHCs partici-
pated. Recruitment took place from November 2018 to
May 2019. Participants from the first CMHC were re-
cruited from an inpatient unit which also offered out-
patient care. From the second CMHC, health
professionals from one outpatient unit participated. Par-
ticipants from the third CMHC were recruited from four
units, two outpatient and two inpatient.
The study was carried out within three different Nor-
wegian health trusts: i.e., two in the east and one in the
north. These health trusts’ services for patients with
psychotic disorders include acute psychiatric units, units
for the treatment of psychotic disorders, and different
outpatient care options. The participating hospital trusts’
catchment areas include cities, smaller towns, and rural
regions. The municipalities in these areas also provide
mental health services. The participating CMHCs’ SDM
fidelity scores were 1, 3, and 3 after 18 months, respect-
ively, indicating a range from no implementation to a
moderate degree of implementation.
Participants
The head of each CMHC decided which health profes-
sionals to invite to participate in the study, based on the
criterion that they have experience using decision-
making practice with patients with psychotic disorders.
Eleven women and seven men participated. Nine of the
18 participants worked exclusively in outpatient treat-
ment, six worked in both inpatient and outpatient treat-
ment, and three worked exclusively in inpatient
treatment. The three participants who worked exclu-
sively with inpatient treatment were psychiatrists. Seven
of these 18 health professionals had participated in the
workshop previously: one from focus group 1, four from
focus group 2, and two from focus group 3. Table 1
shows an overview of the participants.
In Norwegian mental health care, psychiatrists and med-
ical doctors are responsible for prescribing medications,
while nurses and social educators are responsible for ad-
ministering them. Nurses, social educators, psychiatrists,
and psychologists each have individual treatment respon-
sibilities in outpatient care. However, according to the
Mental Health Care Act, a psychiatrist or clinical psych-
ologist is responsible for legally based decisions [16].
Data collection
We conducted three focus group interviews. This
method was considered appropriate to the study goals,
as interactions within focus groups can highlight partici-
pants’ experiences and provide a framework of under-
standing [27]. The interviews were conducted using a
thematic guide designed by the research group, which
includes the third author who had prior user experience.
The thematic guide developed for this study is provided
as Additional File 1. Each interview was begun with an
open-ended question asking participants to share their
SDM experiences with patients with psychotic disorders.
The interviewer then asked questions about their under-
standing of the SDM concept, whether and how they
practice SDM, and their understanding of inhibitors/
promoters of SDM. The questions were all open-ended
and aimed to allow the participants to freely share their
experiences. The interviews were conducted during May
and June 2019. We conducted the 60–90-min interviews
in a meeting room at the participating CMHC. The first
and third authors co-led each interview: e.g., the latter
paid special attention to the dialogue between the partic-
ipants and took notes. Both asked for more details when
necessary to clarify the participant’s statements.
Data analysis
After each focus group interview, the first and third au-
thors summarized their impressions and reflections. In-
terviews were audio recorded and transcribed verbatim
by the first author. Information about each participant’s
profession and whether they worked in inpatient or out-
patient treatment was included in the transcript, as
health professionals from different contexts participated.
The materials were analysed as a whole, and the unit of
analysis was the transcribed text from the three
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interviews [24]. The first author read the transcribed in-
terviews several times to gain a familiarity with the ma-
terial. Meaning units were identified and labelled by
code (i.e., words, sentences, or paragraphs relating to
each other through their content and context) [24]. Con-
densing involved writing a shorter text while preserving
the core meaning. The first, second, third, and last au-
thors discussed and compared the codes for differences
and similarities before they were sorted into categories
describing the content on a manifest level [23]. At this
time, the analysis was discussed among a group of Ph.D.
students during a qualitative methods course meeting
led by a teacher at the university with comprehensive ex-
perience with qualitative methods. The preliminary re-
sults were also presented to colleagues. The feedback
from these two groups was included in further analysis
and compared to our preliminary results. This led to a
broader understanding of the material. Two overarching
themes unifying the threads running through the cat-
egories were identified through interpretation of the la-
tent content. Themes and categories were compared
with the interview data to ensure that they covered the
use of SDM as stated by the participants [24]. Finally,
the categories were presented using representative
quotes from the participants to anchor the content. In
selecting the quotes, we emphasized solid anchorage in
the text and differentiating between categories [23, 24].
The first author had a background as a social educator
with several years working in acute psychiatry. The sec-
ond author was a psychiatric nurse with extensive ex-
perience treating patients with schizophrenia and other
psychoses. The author with prior user experience con-
tributed a different perspective to the analysis process,
challenging the first author’s position and resulting in a
reflexive process that provided a more meaningful un-
derstanding of the participants’ experiences [28]. The
fourth author is professor emeritus, a clinical psychiatrist
and a mental health services researcher with experiences
from doing many studies, including as principal investi-
gator for the multicenter study which includes the
current study. The last author is sociologist and has
been working with health services research in mental
health care for many years. The categorization of find-
ings was supported using NVivo 11 pro.
Ethical considerations
The participants were informed both verbally and in writing
about the study before they signed their voluntary, informed
consent. Each interview was anonymized by removing any
identifying information, to ensure participant confidentiality.
Data were stored on a secure research server approved by
the Data Protection Officer at the Innlandet Hospital Trust.
The ethical principles of the World Medical Association’s
2013 Declaration of Helsinki were followed. The study was
approved by the Regional Committee for Medical and
Health Research Ethics (REC South-East, reg. no 2015/2169).
The study was also approved by the Data Protection Officer
at each participating health trust.
Results
The analysis resulted in two main themes. The first
theme, the SDM concept, consisted of two categories re-
lated to health professionals’ experiences with under-
standing and practicing SDM. The second theme,
barriers to SDM, consisted of two categories related to
health professionals’ experiences with barriers to SDM.
Theme: the SDM concept
Providing information
Several participants stated that SDM involves providing
patients with information. They also said that they
mainly provide information about the patient’s diagnosis
and state of health. Some reported only giving verbal in-
formation, while others said they also provide a written
brochure. Some participants reported using a fill-in form
or a board on which they draw shapes, while others use
different websites to show videos. One participant
expressed that it is important to make the information
easily understandable and non-threatening, using lan-
guage that the patient understands. Others said psycho-
education is useful for informing patients about their
disorder:













Psychiatrist 1 6 1 8 3 3 2
Psychologist 2 2 2




Nurse 1 2 3 1 2
Social educator 2 2 2
Total 6 7 5 18 9 3 6
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I think psycho-education is important in relation to
a psychosis diagnosis. I find that people who have
an established diagnosis really know very little about
their disorder. And that it is rather mysterious in a
way. (Nurse, outpatient care)
Some participants noted that they provide information
about different treatment options to allow patients to
make choices in line with their values. The same partici-
pants expressed that it is most important that patients
receive the information they need to make choices and
that their voice is heard:
The essence of it, as I see it, is that the patient’s voice
should be heard. The person should be able to express
his opinion. It should be given weight in the conversa-
tion. (Psychiatrist 1 [P1], in- and outpatient care)
Several participants reported using SDM in their prac-
tice. They said that patients in both out- and inpatient
facilities are given the opportunity to make joint deci-
sions. One participant stated that SDM implies both
providing information as well as one can and receiving
the best information possible. Another said that SDM is
always used.
Medication treatment decisions
Many participants said that SDM is a question of
whether a patient should have antipsychotic medication.
One psychiatrist expressed this as:
What I’ve said before, when I’ve been asked that
question, is that the question is often whether the pa-
tient should have medicine or not. And the next thing
is that if they have used medications before, then they
may have an idea about what type of medicine they
want or don’t want. Apart from that, they haven’t the
least idea about what kind of medicine they want. If
they haven’t taken medicine before, then they have
no idea whether to take this medicine or that medi-
cine. It’s only [a matter of whether they should have]
medicine or not. (P1, in- and outpatient care)
Some participants stated that they provide general infor-
mation about different types of antipsychotic medication
and alternative forms of administration. They said that
patients are asked about their experiences with anti-
psychotic medication. Some psychiatrists said that their
choice of medication is based on written information
and their own clinical experience. Other psychiatrists re-
ported that patients are willing to try a medicine if they
present it to them. Several participants expressed their
belief that health professionals know what is best for the
patient:
You should never have to get so ill that you actually
have to go to hospital again, but then you have to
have a good dialogue with us. So that I can make
the choices for you that are the best in terms of dos-
ages and quantities and types of medication. (P2,
outpatient care)
Several participants said that it is important to them to
monitor any side effects and that they are willing to col-
laborate with the patient to choose an alternative medi-
cation if side effects are experienced. Some noted that it
is particularly important to monitor weight gain closely,
and that they had focused too little on this side effect in
the past. Some participants mentioned that it is import-
ant to inform patients of the consequences of discon-
tinuing a medicine.
Some participants stated that they refer patients to a
treatment alternative if they do not want to take anti-
psychotic medication. Several participants said that other
treatment options are offered in addition to medication
treatment (e.g., family therapy, cognitive therapy, job
support). Some participants said they wish their work-
place offered more than medical treatment and counsel-
ling. Others reported finding it challenging to present
patients with alternatives because they feel there are no
clear distinctions between different methods and treat-
ment approaches, such as when deciding whether to
base treatment on a psychodynamic, cognitive, or behav-
ioural approach. These participants stated that instead of
presenting such alternatives, they focus on the patients’
treatment goals and what the patient wants to work on.
Theme: barriers to SDM
Trust and therapeutic alliance take time
The participants said that they could spend months or
even years learning what is important to some patients
because it takes a long time for their patients to feel
confident enough to share their wishes with a therapist:
It’s quite true what’s been said here now, the time
factor is very important, you spend time building an
alliance and trust. And the quality of SDM, or the
quality of the choices made, will increase when you
trust the person who’s suggesting something. So
that’s why I support this idea that the time factor is
absolutely crucial. (P2, outpatient care)
Several participants conveyed that patience is needed to
help patients to open up and talk about symptoms that
they had been too distrustful to mention previously. Ac-
cording to several participants, as the patient’s suspi-
cions decrease and their confidence in the relationship
increases, a firmer basis for co-operation on treatment
options develops.
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Several participants shared that a therapeutic alliance
needs to be built to access information about what the
patient wants, and to help them:
That’s what I think is most important. To build an
alliance between you and your patients. (P3, in- and
outpatient care)
Some participants said that a good therapeutic alliance is
important for building mutual trust between the patient
and professional. Therapist continuity was mentioned by
some as important for building a good alliance with the
patient. Some participants said that dialogue is a useful
tool for discovering what is most important to the
patient.
Although most participants agreed that time and
therapeutic alliance are needed to identify what is im-
portant to the patient, a few participants took a different
view. One participant spoke about using the alliance to
communicate the importance of a treatment:
It’s an important part of treatment, or one of the
most important parts of treatment, is to build a
therapeutic alliance and at least try to increase the
patient’s insight into the disease and then let him
know that medication can be a really important part
of treatment. (P4, inpatient care)
Another participant stated:
We need to get an alliance that results in the patient
agreeing to a little more than they might have ex-
pected, so that I can feel reassured and so that they
can be confident that we are doing things pretty
much in the right way. (P2, outpatient care)
This person talked about using the alliance to persuade
the patient to accept more of the treatment the thera-
pists wanted to offer.
Limited understanding of one’s own situation
Almost all the participating psychiatrists and several
other participants reported experiencing challenges with
using SDM with patients with psychotic disorders whom
they felt had a limited understanding of the conse-
quences of the disorder for their lives. Some of the par-
ticipants said early in the interview that they aimed to
come to an agreement with the patient. Later in the
interview, the same participants reported that, in many
situations, they had to make the decision for the patient
because of the patient’s limited understanding. Some
participants justified this based on the patient’s ambiva-
lence; in situations in which it was difficult to get a clear
answer from the patient, the professionals must make
the choice. Others said that the sickest patients often re-
fuse treatment. This was illustrated by a dialogue among
the psychiatrists P3 (in- and outpatient care), P5 (in-
patient care), and P6 (outpatient care):
P3: “The sickest people say no to whatever we offer
them.”
P5: “Yes, they do.”
P3: “In psychiatry, the ones who need the most
treatment generally say no. That’s my experience.”
P6: “They say no because they’re paranoid and sus-
picious.”
P5: “They’re in very bad shape.”
Several participants found it particularly challenging if
their patient was psychotic and said there are situations
in which they, as therapists, must make the decisions.
One participant also stated that SDM is not necessarily
possible beginning at the patient’s first contact with the
therapist:
You’re psychotic, coming on strong with some para-
noia. So you’re not capable of making decisions here
and now, but later on we can talk about SDM. (P5,
inpatient care)
The participants described situations with violent or sui-
cidal patients as especially challenging. A couple of par-
ticipants described these as demanding situations in
which they must think carefully about whether to ignore
the patient’s wants. Others said it is difficult to arrive at
a common solution if the therapist disagrees with the
patient. Some felt that SDM is not suitable for all
patients.
I don’t think SDM fits all types of patients and diag-
noses. You have to be a bit realistic. (P3, in- and
outpatient care)
This participant later continued:
It’s good that those who can decide are allowed to
decide, but not everybody. The ones who are very
sick, they can’t decide. (P3, in- and outpatient care)
Another participant emphasized that the therapist can-
not let patient involvement go so far that the therapist
just gives in:
But by law, our patients have the right to user par-
ticipation. Then I’m thinking about what you said,
and I said something about it just now, if we were
to go whole hog, and now I’m talking about the
ones who are here voluntarily, then we’d be giving
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way too much if we didn’t use our own expertise and
kind of try to influence [the decision] in one direction
or another. If it’s too much, it’s informal coercion, if
it’s too little, we’re just giving way. You have to find
the right balance. (Nurse, outpatient care)
Although most participants stated that they had to make
treatment decisions for patients, especially those who
are sickest, some had different views:
Choice means choice. Isn’t that the way life is for
many people? Suddenly you’re affected and then you
make a choice, and maybe in fact it was a stupid
choice. (Social educator, in- and outpatient care)
Some participants said that patients with psychotic dis-
orders must be fully respected. Health professionals
must be willing to let these patients make a choice and
live with the consequences of that choice, even if they
disagree.
Discussion
This study shows that when treating patients with
psychosis, health professionals limit their SDM approach
to giving their patients information about their diagnosis
and health situation, and that SDM is predominantly a
matter of choosing between antipsychotic medication
types. Psychological and social treatment options are
usually offered as a supplement, not an alternative, to
medication treatment. The study also shows that health
professionals feel it is more difficult to practice SDM
with patients who have a limited understanding of their
own situation and when they need considerable time to
build trust and a therapeutic alliance.
The understanding and practice of SDM
These mental health professionals emphasized that they
provide patients with information about their condition,
a core area of SDM [12]. They try to make this informa-
tion easily comprehensible and non-threatening, such as
with psycho-education, which can facilitate SDM [12].
The professionals are thus practising basic elements of
SDM. However, as we can see in Table 2 the study also
shows that it is unclear how far this is followed up with
other elements of SDM, e.g., such as presenting different
treatment options, considering the patient’s values and
preferences, or discussing the advantages and disadvan-
tages of alternatives [2].
The study shows that, to a limited extent, health pro-
fessionals report collaborating with patients on treat-
ment choices. Simultaneously, several participants
believe that they are using SDM. This shows that the
health professionals quoted herein have a different, and
limited, understanding of the concept of SDM. This is
consistent with previous research showing that health
professionals believe they are using SDM, while
observer-based outcomes indicate that it has not yet
been implemented in clinical practice [29].
That the health professional participants in this study
describe SDM as being largely about medication treat-
ment choices suggests that a medical understanding of
treatment predominates. This is surprising, since several
of the participants are psychologists and other profes-
sionals with backgrounds in health and social care. The
participants explained that psychological, social, and
other treatment interventions may be offered—as a sup-
plement, not an alternative—to medication treatment.
That these participating CMHC staff were intended to
implement an EBP on antipsychotic medication may
Table 2 How the findings reflect essential elements of SDM as described by Makoul et al. [2]
Essential elements of SDM Findings in this study
Define/explain problem The participants inform the patients about the diagnosis and state of health.
Present options The participants inform the patients to some degree about different antipsychotic medications. If psychological and
social treatment options are presented, it is usually as a supplement, not as an alternative, to medication.
Discuss pro/cons Usually discussed after prescribing an antipsychotic medication and not as part of a SDM process before making the
treatment choice.
Patient values/preferences Some participants mention the importance of providing care in line with patients’ values, but our results do not
support that this is participants’ everyday practice.
Discuss patient ability/self-
efficacy
The findings do not give a clear answer as to what degree the participants discuss patient ability/self-efficacy.
Doctor knowledge/
recommendation
Some participants present an antipsychotic medication to the patients. However, our findings do not support that it is
a recommendation based on a SDM process where different options and their pros/cons have been discussed in light
of the patients’ values.
Check/clarify understanding The findings are unclear regarding to what degree the health professionals’ check the patients’ understanding.
Make or explicitly defer
decision
The findings suggest that health professionals often make the decision due to the patients’ limited understanding of
their own situation. This is a practice more based on a clinical-led model than on SDM.
Arrange follow-up The participants describe using time to identify what is important for the patients suggesting that they follow-up deci-
sions over time. However, it is unclear how and to what extent this is implemented as part of an overall SDM process.
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have directed their focus towards medication treatment.
However, in recent years both the Norwegian Ministry
of Health and service user organizations have strongly
focused on non-pharmaceutical treatment alternatives
[21]. Thus, the participants should have emphasized al-
ternatives more than was done herein.
That half of those in our sample were psychiatrists
and medical doctors may help explain the limited extent
to which they offer alternative interventions. Another
interview study found that the prevailing attitude among
psychiatrists in community services is that antipsychotic
medication is an important aspect of treating patients
with psychotic disorders [14]. Psychiatrists often have a
leading role on treatment teams, which may also have
given them a more dominant role in the focus group dis-
cussions, potentially leading to pressure for a consensus
on medication approaches. The other half of the sample
was divided among different professions, with only two
psychologists participating. This may have made it chal-
lenging for others to express different experiences, pos-
sibly explaining why they did not describe any clear
alternative to the medication approach.
The participating health professionals were offered
training and implementation guidance. However, that
they report practicing only limited aspects of SDM
might also be explained by the fact that 11 of the 18 par-
ticipants did not attend the training course and therefore
lacked the requisite knowledge. Another explanation
may be that a one-day training course in which SDM is
only one of several topics is insufficient. The implemen-
tation guidance was provided over 18 months and SDM
was one of 15 implementation areas. This may have
made it challenging to focus adequately on SDM and
contributed to their limited practice of this approach.
It is important to interpret the participants’ under-
standing of medical treatment within the context of
current guidelines, which state that treatment with anti-
psychotic medication is recommended and that psycho-
logical interventions are most effective when combined
with medication [30]. This helps explain why the med-
ical treatment approach apparently predominates. Some
participants stated that they would like to offer alterna-
tives to medical treatment and counselling, which is con-
sistent with the emphasis by service user organizations
and health authorities on the importance of patient
choice between different treatment options, including
medication-free services [21].
The study findings show that patients with psychotic
disorders have limited involvement in SDM where
medication-free services are an alternative. Some health
professionals do inform their patients about different
types of antipsychotic medication and explore the pa-
tient’s previous experiences. Other patients may only be
presented with one type of antipsychotic medication and
are scarcely involved in collaboration. At the same time,
several health professionals expressed a willingness to
collaborate on choosing another medication if the pa-
tient has experienced side effects. This is important be-
cause the decision to risk metabolic syndrome, tardive
dyskinesia, or reduced libido in exchange for symptom
relief is not only a medical, but a personal matter [31].
However, a practice consistent with the intentions of
SDM implies that risks and disadvantages (e.g., side ef-
fects) are discussed before a choice is made [2].
Barriers to practising SDM
Limited time is one of the most commonly reported bar-
riers to SDM implementation [32]. The professionals in
our study also described time as a barrier. They say it
can take months to years to build a therapeutic alliance
that enables SDM. They consider this duration necessary
to reduce suspicion and learn what is important to the
patient. No previous findings have supported the notion
that SDM increases consultation time [33]. Some studies
show that SDM can be implemented in mental health
without increasing the time involved. For example, Dee-
gan [34] showed that despite time constraints, technol-
ogy and peer support can facilitate SDM. Despite this,
decisions in mental health care can be more complex
and take longer than in other fields of medicine [12].
Decisions are thus not necessarily made in one consult-
ation, but over several consultations. This underlines the
importance of being patient and taking time to build an
alliance based on trust, which can lead to a positive dia-
logue that elicits the patient’s values and preferences.
The therapeutic alliance highlights the need for good
co-operation when using SDM [35]. This can be challen-
ging when patients have limited decision-making cap-
acity, as described by the participants herein. In such
cases, co-operation is often abandoned in favour of a
more asymmetric relationship [14]. This study shows
that although the therapeutic alliance is important, it
can also be used to make the patient agree with the ther-
apist. For example, the participants described how they
use their alliance to make the patient accept more of the
treatment recommended by the health professional.
Participants described patients’ limited understandings
of their own situations as a barrier to SDM, which con-
curs with previous research [12]. For this reason, health
professionals believe they must make the treatment deci-
sion for the patient. This may be seen as a practice based
more on a clinician-led model than on SDM, a view con-
sistent with previous research showing that SDM is in-
frequently used in mental health care [3].
Health professionals sometimes justify making unilat-
eral decision by vaguely stating that the patients are very
sick. Alternatively, they state more specifically that the
patients are psychotic, violent, or suicidal. In some of
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these situations, SDM will not necessarily take place during
the initial contact with the therapist. However, it is interest-
ing that the assessment of patients’ limited understanding
of their situation persists and is described by the partici-
pants as being a major barrier to SDM. This is contradicted
by research findings showing that the majority of people
with schizophrenia are considered to have adequate
decision-making capacity [36]. This is particularly interest-
ing because several of the health professionals we inter-
viewed work in an outpatient setting with patients who
mainly live in the community. In comparison with inpa-
tients, one would expect these outpatients to have better
functioning and be more likely to be judged capable of
making decisions. SDM should therefore be used more
with this group of patients.
Nevertheless, participants state that they must make
decisions for their patients in many contexts. One ex-
planation for this may be the generalization that
emerged in the interviews based on patients whose func-
tioning is lowest because it was difficult to focus the in-
terviews on outpatients with higher levels of functioning.
The interviews often contain descriptions of experiences
with patients in crisis and in which hospitalization must
be considered. Some participants worked only in in-
patient care (n = 3), while some worked in both in- and
outpatient care (n = 6); thus, they would naturally have
experience with sicker patients. Another explanation is
that health professionals’ views on the treatment of pa-
tients with psychotic disorders are based on a more
clinician-led model. It is important to note here that
amendments to the Mental Health Act in 2017 gave pa-
tients greater self-determination [16]. If patients have
decision-making capacity, they have a right to make
choices with which clinicians disagree, and a right to
make poor choices. The findings of this study suggest a
potential for greater reflection on the significance of the
law amendments, in terms of values and practicalities.
Although several health professionals in this study stated
that they do not give patients any responsibility in the
decision-making process, some also expressed that one
should be more willing to let patients decide, even if the de-
cisions can be considered poor choices. The latter is in line
with health policy guidelines on increased service user par-
ticipation and autonomy [5]. However, it is also important to
realize that some patients with acute psychosis will not have
decision-making capacity. Decision-making capacity is con-
textual, it can vary over time and must be understood in re-
lation to each specific decision to be made [37]. This study
suggests a potential for increasing the focus on the meaning
of decision-making capacity in the implementation of SDM.
Strengths and limitations
A strength of this study is that the interactions among the
focus group participants provided detailed descriptions of
their experiences [27, 38]. The involvement of a researcher
with prior user experience in most phases of the study is a
strength that may have enhanced the quality of the study
[39]. Four researchers were involved in the analysis, which
was presented both to colleagues and within a qualitative
methods course. This is a strength because it ensured re-
flexive processes in which we sought out positions that
challenged our preunderstandings.
There are also several potential study limitations. First,
half the participants were psychiatrists or medical doc-
tors. However, two of the groups only included one
psychiatrist. In these two groups, the psychiatrists spoke
slightly more than the other participants did. Most of
the participants promoted their views, both the psychia-
trists and other professions. However, we cannot guar-
anty that the psychiatrists – with a leading role in the
team - did not influence group consensus and thus si-
lenced dissenting voices [27]. This may be a limitation of
our recruitment strategy. The moderators tried to shift
the attention to participants that spoke less by seeking
eye contact and if necessary asking direct questions. Sec-
ond, including participants from the same clinical team
may have influenced the dynamics in the focus group as
norms in the teams may have silenced participants with
dissenting experiences. Further, synergism in the group
may have allowed the participants to strengthen their
experiences of how difficult it is to practice SDM for pa-
tients with a psychotic disorder and contributed to more
critical comments [27]. Third, the study was conducted
in a limited geographical area and thus may represent
only local practices. Fourth, we only included health pro-
fessionals’ perspectives, a few of whom contributed less
than others. Fifth, we included those working in both in-
patient and outpatient units, although we tried to
minimize this issue by contextualizing the participants’
experiences (i.e., identified each quote with the partici-
pant’s profession and workplace). Sixth, we do not know
how many of our participants’ patients were in involun-
tary versus voluntary treatment, which may have influ-
enced the interview conversations. Seventh, we only
interviewed participants working at CMHCs where SDM
had not, or only moderately, been implemented, possibly
explaining why they spoke more about difficulties with
SDM and less about success factors.
Finally, further interviews may have provided add-
itional perspectives. However, in applying a qualitative
design, we did not intend to generalize the participants’
experiences. The intention was to elucidate the
phenomenon through good descriptions from the partic-
ipants. The third interview confirmed previous themes,
without providing new perspectives. That other studies
[12] have found some of the same results may
strengthen the validity of our findings beyond the partic-
ipants in this study. We suggest that the results may be
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relevant to those working in mental health services that
treat patients with psychotic disorders.
Conclusions
This study shows that health professionals’ inclusion of
patients with psychotic disorders in decisions regarding
their treatment is limited. Health professionals describe
an understanding of SDM that is relatively limited to
providing information about the patient’s health situ-
ation and medication treatment choices. SDM is primar-
ily not practiced to the degree of collaboration between
health professionals and patients that its definition in-
tends. This suggests that the current SDM practice is
not in line with guidelines by health authorities.
This study shows that more comprehensive SDM
training is needed, with focuses on values, attitudes, how
to carry out SDM in clinical practice, and, potentially,
communication skills. The findings suggest that imple-
mentation support should be aimed more precisely at
SDM, to increase the chances of health professionals
adopting the approach.
Additional research addressing health professionals’
use of SDM with patients with psychotic disorders will
be needed. Such research should focus on the factors
that lead to health professionals to make greater use of
SDM. Additional research may include investigating
both health professionals’ and society’s understandings
of their roles and responsibilities in empowering this pa-
tient group. Future research might also more closely
examine how decision-making capacity is understood
and assessed in carrying out SDM for patients with
psychotic disorders.
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